Integrase Inhibitors

DBCAT001872Pharmacologic classJ05AJ

Compounds which inhibit or antagonize biosynthesis or actions of integrase. A DrugBank category of 5 drugs. 4 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J05 — ANTIVIRALS FOR SYSTEMIC USE
J05A — DIRECT ACTING ANTIVIRALS
J05AJ — Integrase inhibitors
Also known as: Inhibitors, Integrase
Drugs: Cabotegravir
Dolutegravir
Elvitegravir
HIV Integrase Inhibitor
Raltegravir

What you can answer from here — as of August 24, 2016

5DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

222Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Integrase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.